1. Home
  2. ADV vs LCTX Comparison

ADV vs LCTX Comparison

Compare ADV & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advantage Solutions Inc.

ADV

Advantage Solutions Inc.

HOLD

Current Price

$42.31

Market Cap

438.2M

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.31

Market Cap

388.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADV
LCTX
Founded
1987
1990
Country
United States
United States
Employees
73000
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
438.2M
388.6M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
ADV
LCTX
Price
$42.31
$1.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$45.83
$6.25
AVG Volume (30 Days)
76.6K
1.4M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,556,000.00
Revenue This Year
$0.63
$109.40
Revenue Next Year
$0.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.24
52 Week Low
$0.49
$0.64
52 Week High
$46.80
$2.09

Technical Indicators

Market Signals
Indicator
ADV
LCTX
Relative Strength Index (RSI) 69.76 40.54
Support Level $1.00 $1.14
Resistance Level $46.80 $1.31
Average True Range (ATR) 4.11 0.08
MACD -0.39 -0.00
Stochastic Oscillator 73.73 31.67

Price Performance

Historical Comparison
ADV
LCTX

About ADV Advantage Solutions Inc.

Advantage Solutions Inc provides outsourced sales, marketing, merchandising, sampling, and retailer support services to consumer packaged goods manufacturers and retailers across North America. Its services are designed to support distribution, retail execution, shopper engagement, and private brand development across both physical and digital commerce environments. The company serves various clients across grocery, mass, club, retail pharmacy, convenience, and other channels. It operates through three reportable segments: Branded Services, Experiential Services, and Retailer Services. The majority of the revenue is derived from the Experiential Services segment, which provides in-store and digital sampling programs, demonstrations, and experiential events for manufacturers and retailers.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: